Bank of America
MGRX icon

Bank of America’s Mangoceuticals MGRX Stock Holding History

Bank of America’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-107
Closed -$79 – 6428
2025
Q4 		$79 Sell
107
-69
-39% -$112 ﹤0.01% 6868
2025
Q3 		$386 Buy
176
+13
+8% +$24 ﹤0.01% 7625
2025
Q2 		$247 Buy
163
+148
+987% +$278 ﹤0.01% 7804
2025
Q1 		$29 Buy
15
+4
+36% +$14 ﹤0.01% 8064
2024
Q4 		$27 Buy
11
+1
+10% +$3 ﹤0.01% 7974
2024
Q3 		$37 Buy
+10
New +$47 ﹤0.01% 7878
2023
Q4 		– Sell
-8
Closed -$102 – 8142
2023
Q3 		$102 Buy
+8
New +$150 ﹤0.01% 7466

Other funds holding MGRX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Bank of America's MGRX Position: Q1 2026 in Review

Bank of America sold out of Mangoceuticals (MGRX) in Q1 2026, closing a stake of 107 shares — an estimated $79 sold.

Bank of America first reported a position in MGRX in Q3 2023 and held it in 7 quarters. The position peaked at $386 in Q3 2025. 18 funds tracked by Wall St. Rank hold MGRX as of Q1 2026.

  • Bank of America reported no remaining Mangoceuticals position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 107 Mangoceuticals shares in Q1 2026, an estimated $79.
  • Bank of America first reported a position in Mangoceuticals in Q3 2023 and held it in 7 quarters.
  • Bank of America's Mangoceuticals position peaked at $386 in Q3 2025.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.